Company: FLDDW
Filing Date: 2025-07-11
Form Type: S-1
Source: 0001213900-25-062935
Chunk: 3

Company: Fold Holdings, Inc.
Filing Date: 2025-07-11
Form: S-1
Chunk 3
---
 proceeds under the Facility to the Company will depend on the frequency and prices at which the Company sells shares of Common Stock to SZOP. The Company is registering the resale or other disposition by SZOP of the shares of Common Stock they may be sold from time to time under the Facility pursuant to that certain registration rights agreement by and between the Company and SZOP, dated as of June16, 2025 (the “SZOP RRA”). Cohen may offer, sell or otherwise dispose of all or a portion of the Placement Shares hereby registered either publicly or through private transactions at prevailing market prices or at negotiated prices. SZOP may offer, sell or otherwise dispose of all or a portion of the shares of Common Stock acquired under the Facility and hereby registered either publicly or through private transactions at prevailing market prices or at negotiated prices. We will bear all costs, expenses and fees in connection with the registration of the shares of our Common Stock, including with regard to compliance with state securities or “blue sky” laws, subject to the Expense Cap (as such term is defined in Section 6.13 of the Facility). The timing, frequency and volume of any resale or other disposition of the shares of Common Stock registered hereunder are within the sole discretion of the Selling Stockholders. SZOP may be deemed an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act with respect to the resale of shares of Common Stock acquired by it under the Facility. Although SZOP is obligated to purchase shares of our Common Stock under the terms and subject to the conditions and limitations of the Facility, to the extent we choose to sell such shares of our Common Stock to SZOP (subject to certain conditions), there can be no assurances that we will choose to sell any shares of our Common Stock to SZOP, or that SZOP will sell any or all of the shares of our Common Stock, if any, purchased under the Facility pursuant to this prospectus. The Selling Stockholders will bear all commissions and discounts, if any, attributable to the resale of shares of our Common Stock. See “ Plan of Distribution” for additional information. We are an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), and are subject to reduced public company reporting requirements. This prospectus complies with the requirements that apply to an issuer that is an emerging growth company. Our Common Stock is listed on Nasdaq under the symbol “FLD.” On